BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 14528055)

  • 1. Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.
    Moore DJ; Dawson VL; Dawson TM
    Neuromolecular Med; 2003; 4(1-2):95-108. PubMed ID: 14528055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system.
    Petrucelli L; Dawson TM
    Ann Med; 2004; 36(4):315-20. PubMed ID: 15224658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders.
    Chung KK; Dawson VL; Dawson TM
    Trends Neurosci; 2001 Nov; 24(11 Suppl):S7-14. PubMed ID: 11881748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin proteasome system in synaptic and axonal degeneration: a new twist to an old cycle.
    Korhonen L; Lindholm D
    J Cell Biol; 2004 Apr; 165(1):27-30. PubMed ID: 15067020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of the ubiquitin-proteasome system in Parkinson's disease.
    McNaught KS; Olanow CW; Halliwell B; Isacson O; Jenner P
    Nat Rev Neurosci; 2001 Aug; 2(8):589-94. PubMed ID: 11484002
    [No Abstract]   [Full Text] [Related]  

  • 6. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring the ubiquitin/proteasome system in conformational diseases.
    Lindsten K; Dantuma NP
    Ageing Res Rev; 2003 Oct; 2(4):433-49. PubMed ID: 14522245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
    Lim KL; Lim TM
    IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are ubiquitination pathways central to Parkinson's disease?
    Giasson BI; Lee VM
    Cell; 2003 Jul; 114(1):1-8. PubMed ID: 12859888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the ubiquitin-proteasome hypothesis of neurodegeneration in vivo.
    Hernández F; Díaz-Hernández M; Avila J; Lucas JJ
    Trends Neurosci; 2004 Feb; 27(2):66-9. PubMed ID: 15106649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aggravating role of the ubiquitin-proteasome system in neurodegenerative disease.
    Hung CC; Davison EJ; Robinson PA; Ardley HC
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):743-5. PubMed ID: 17052187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
    McNaught KS; Olanow CW
    Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders.
    Layfield R; Cavey JR; Lowe J
    Ageing Res Rev; 2003 Oct; 2(4):343-56. PubMed ID: 14522239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
    Stenoien DL; Mielke M; Mancini MA
    Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.
    Jana NR; Nukina N
    J Chem Neuroanat; 2003 Oct; 26(2):95-101. PubMed ID: 14599658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
    Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
    J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.